When encountering patients with malignant tumors who present with elevated white blood counts and C-reactive proteins levels, serum G-CSF and IL-6 measurements and immunostaining tumor cells with anti-G-CSF and anti-IL-6 monoclonal antibodies should be considered for diagnosis of G-CSF- and IL-6-producing tumors. This evidence concerns the gene CRP and neoplasm.